PPP
ARKG icon

Private Portfolio Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Private Portfolio Partners’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,519
Closed -$233K – 257
2021
Q2 		$233K Buy
2,519
+25
+1% +$2.13K 0.07% 232
2021
Q1 		$221K Buy
2,494
+347
+16% +$34.4K 0.07% 220
2020
Q4 		$200K Buy
+2,147
New +$171K 0.07% 218

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Private Portfolio Partners's ARKG Position: Q3 2021 in Review

Private Portfolio Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 2,519 shares — an estimated $233K sold.

Private Portfolio Partners first reported a position in ARKG in Q4 2020 and held it in 3 quarters. The position peaked at $233K in Q2 2021. 470 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Private Portfolio Partners reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • Private Portfolio Partners sold 2,519 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $233K.
  • Private Portfolio Partners first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 3 quarters.
  • Private Portfolio Partners's ARK Genomic Revolution ETF position peaked at $233K in Q2 2021.
  • 470 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Private Portfolio Partners's 13F filing for Q3 2021, filed 4 Nov 2021.